<?xml version="1.0" ?><text author="Antonio  Carlos Rosário Vallinoto, Izaura Cayres-Vallinoto, Maria  Alice Freitas Queiroz, Marluísa  de Oliveira Guimarães Ishak, Ricardo Ishak" dateCollected="2019-11-03" id="autogum_academic_doc629" shortTile="influence-immunogenetic" sourceURL="https://www.mdpi.com/1999-4915/11/11/974/htm" speakerCount="0" speakerList="none" title="Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons" type="academic">
<head>
<s type="frag">
1	CD	1
.	.	.
</s>
<s type="frag">
Introduction	NN	introduction
</s>
</head>
<p>
<s type="frag">
Human	NN	Human
</s>
<s type="decl">
T-lymphotropic	NNP	T-lymphotropic
virus	NN	virus
1	CD	1
(	-LRB-	(
HTLV-1	NNP	HTLV-1
)	-RRB-	)
is	VBZ	be
a	DT	a
<hi rend="italic">
Deltaretrovirus	NNP	Deltaretrovirus
</hi>
,	,	,
endemic	JJ	endemic
in	IN	in
Japan	NNP	Japan
,	,	,
Caribbean	NNP	Caribbean
,	,	,
South	NNP	South
America	NNP	America
,	,	,
Sub-Saharan	NNP	Sub-Saharan
Africa	NNP	Africa
,	,	,
and	CC	and
Melanesia	NNP	Melanesia
.	.	.
</s>
</p>
<p>
<s type="decl">
HTLV-1	NNP	HTLV-1
is	VBZ	be
associated	VBN	associate
with	IN	with
several	JJ	several
different	JJ	different
types	NNS	type
of	IN	of
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
Adult	JJ	adult
T-cell	NNP	T-cell
leukemia/lymphoma	RB	leukemia/lymphoma
(	-LRB-	(
ATLL	NNP	ATLL
)	-RRB-	)
develops	VBZ	develop
in	IN	in
up	RP	up
to	TO	to
5	CD	5
%	NN	%
of	IN	of
infected	VBN	infect
people	NNS	people
,	,	,
and	CC	and
sometimes	RB	sometimes
a	DT	a
chronic	JJ	chronic
neurodegenerative	JJ	neurodegenerative
inflammatory	JJ	inflammatory
disease	NN	disease
called	VBN	call
HTLV-1-associated	JJ	HTLV-1-associated
myelopathy	NN	myelopathy
(	-LRB-	(
HAM	NNP	HAM
)	-RRB-	)
develops	VBZ	develop
.	.	.
</s>
<s type="decl">
Although	IN	although
a	DT	a
high	JJ	high
percentage	NN	percentage
of	IN	of
people	NNS	people
remain	VBP	remain
asymptomatic	JJ	asymptomatic
during	IN	during
their	PRP$	their
lifetime	NN	lifetime
,	,	,
a	DT	a
great	JJ	great
number	NN	number
of	IN	of
infected	VBN	infect
people	NNS	people
develop	VBP	develop
a	DT	a
large	JJ	large
range	NN	range
of	IN	of
neurological	JJ	neurological
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
Other	JJ	other
opportunistic-like	JJ	opportunistic-like
infections	NNS	infection
,	,	,
such	JJ	such
as	IN	as
Strongyloidiasis	NNP	strongyloidiasis
,	,	,
Norwegian	JJ	Norwegian
scabies	NNS	scabie
,	,	,
infective	JJ	infective
dermatitis	NN	dermatity
,	,	,
as	RB	as
well	RB	well
as	IN	as
autoimmune	NN	autoimmune
syndromes	NNS	syndrome
,	,	,
including	VBG	include
rheumatoid	NN	rheumatoid
arthritis	NN	arthritis
and	CC	and
Sjögren	NNP	Sjögren
’s	POS	's
syndrome	NN	syndrome
,	,	,
have	VBP	have
also	RB	also
been	VBN	be
described	VBN	describe
among	IN	among
HTLV-1	NNP	HTLV-1
carriers	NNS	carrier
.	.	.
</s>
<s type="decl">
In	IN	in
these	DT	these
patients	NNS	patient
,	,	,
the	DT	the
clinical	JJ	clinical
conditions	NNS	condition
appear	VBP	appear
to	TO	to
be	VB	be
the	DT	the
result	NN	result
of	IN	of
the	DT	the
interaction	NN	interaction
between	IN	between
the	DT	the
virus	NN	virus
and	CC	and
the	DT	the
host	NN	host
susceptibility	NN	susceptibility
,	,	,
leading	VBG	lead
to	TO	to
the	DT	the
abnormal	JJ	abnormal
functioning	NN	functioning
of	IN	of
immuno-modulatory	NN	immuno-modulatory
mechanisms	NNS	mechanism
,	,	,
cell	NN	cell
proliferation	NN	proliferation
,	,	,
and	CC	and
inflammation	NN	inflammation
.	.	.
</s>
</p>
<p>
<s type="decl">
HAM	NNP	HAM
is	VBZ	be
a	DT	a
chronic	JJ	chronic
progressive	JJ	progressive
demyelinating	NN	demyelinate
disease	NN	disease
that	WDT	that
affects	VBZ	affect
the	DT	the
spinal	NN	spinal
cord	NN	cord
and	CC	and
the	DT	the
white	JJ	white
matter	NN	matter
of	IN	of
the	DT	the
brain	NN	brain
,	,	,
leading	VBG	lead
to	TO	to
a	DT	a
severe	JJ	severe
clinical	JJ	clinical
syndrome	NN	syndrome
due	JJ	due
to	TO	to
the	DT	the
motor	NN	motor
limitations	NNS	limitation
that	WDT	that
affect	VBP	affect
the	DT	the
lower	JJR	low
limbs	NNS	limb
associated	VBN	associate
with	IN	with
the	DT	the
autonomic	JJ	autonomic
dysfunction	NN	dysfunction
.	.	.
</s>
<s type="decl">
The	DT	the
clinical	JJ	clinical
picture	NN	picture
begins	VBZ	begin
and	CC	and
evolves	VBZ	evolve
insidiously	RB	insidiously
,	,	,
being	VBG	be
difficult	JJ	difficult
to	TO	to
establish	VB	establish
when	WRB	when
the	DT	the
first	JJ	first
symptoms	NNS	symptom
appeared	VBD	appear
.	.	.
</s>
<s type="decl">
The	DT	the
main	JJ	main
signs	NNS	sign
and	CC	and
symptoms	NNS	symptom
of	IN	of
HAM	NNP	HAM
may	MD	may
include	VB	include
gait	NN	gait
disturbance	NN	disturbance
,	,	,
weakness	NN	weakness
,	,	,
and	CC	and
stiffness	NN	stiffness
of	IN	of
the	DT	the
lower	JJR	low
limbs	NNS	limb
.	.	.
</s>
<s type="decl">
The	DT	the
first	JJ	first
manifestations	NNS	manifestation
of	IN	of
the	DT	the
disease	NN	disease
occur	VBP	occur
in	IN	in
the	DT	the
fourth	JJ	fourth
decade	NN	decade
of	IN	of
life	NN	life
and	CC	and
there	EX	there
is	VBZ	be
a	DT	a
2:1	CD	@card@
woman/man	NN	woman/man
ratio	NN	ratio
.	.	.
</s>
<s type="decl">
The	DT	the
incubation	NN	incubation
period	NN	period
differs	VBZ	differ
from	IN	from
patient	NN	patient
to	TO	to
patient	NN	patient
and	CC	and
seems	VBZ	seem
to	TO	to
be	VB	be
shorter	JJR	shorter
in	IN	in
the	DT	the
cases	NNS	case
where	WRB	where
the	DT	the
virus	NN	virus
was	VBD	be
acquired	VBN	acquire
through	IN	through
blood	NN	blood
transfusion	NN	transfusion
.	.	.
</s>
</p>
<p>
<s type="decl">
Two	CD	Two
important	JJ	important
aspects	NNS	aspect
of	IN	of
HAM	NNP	HAM
development	NN	development
have	VBP	have
been	VBN	be
reported	VBN	report
,	,	,
including	VBG	include
the	DT	the
efficiency	NN	efficiency
of	IN	of
the	DT	the
cellular	JJ	cellular
immune	NN	immune
response	NN	response
and	CC	and
the	DT	the
rate	NN	rate
of	IN	of
spontaneous	JJ	spontaneous
expression	NN	expression
of	IN	of
the	DT	the
viral	NN	viral
antigen	NN	antigen
,	,	,
due	JJ	due
to	TO	to
the	DT	the
numerous	JJ	numerous
immunological	JJ	immunological
alterations	NNS	alteration
,	,	,
mediated	VBN	mediate
mainly	RB	mainly
by	IN	by
the	DT	the
expression	NN	expression
of	IN	of
Tax	NNP	tax
(	-LRB-	(
regulatory	JJ	regulatory
protein	NN	protein
of	IN	of
the	DT	the
virus	NN	virus
)	-RRB-	)
in	IN	in
the	DT	the
peripheral	JJ	peripheral
blood	NN	blood
and	CC	and
in	IN	in
the	DT	the
cerebrospinal	JJ	cerebrospinal
fluid	NN	fluid
of	IN	of
patients	NNS	patient
with	IN	with
HAM	NNP	HAM
.	.	.
</s>
</p>
<p>
<s type="inf">
In	IN	in
order	NN	order
to	TO	to
control	VB	control
HTLV-1	JJ	HTLV-1
replication	NN	replication
and	CC	and
the	DT	the
proliferation	NN	proliferation
of	IN	of
infected	VBN	infect
cells	NNS	cell
,	,	,
CD8+	NN	CD8+
</s>
<s type="decl">
T	NN	T
lymphocytes	NNS	lymphocyte
mediate	VBP	mediate
the	DT	the
main	JJ	main
defense	NN	defense
strategy	NN	strategy
of	IN	of
the	DT	the
host	NN	host
immune	NN	immune
system	NN	system
.	.	.
</s>
<s type="decl">
HTLV-1	NNP	HTLV-1
infects	VBZ	infect
mainly	RB	mainly
CD4+	NNP	CD4+
T	NNP	T
cells	NNS	cell
,	,	,
which	WDT	which
are	VBP	be
the	DT	the
central	JJ	central
regulators	NNS	regulator
of	IN	of
the	DT	the
acquired	VBN	acquire
immune	JJ	immune
response	NN	response
,	,	,
deregulating	VBG	deregulate
the	DT	the
host	NN	host
immune	NN	immune
system	NN	system
.	.	.
</s>
<s type="decl">
To	TO	To
establish	VB	establish
persistent	JJ	persistent
infection	NN	infection
,	,	,
HTLV-1	NNP	HTLV-1
deregulates	VBZ	deregulate
CD4+	NNP	CD4+
T	NNP	T
cells	NNS	cell
,	,	,
sometimes	RB	sometimes
leading	VBG	lead
to	TO	to
ATLL	NNP	ATLL
or	CC	or
to	TO	to
chronic	JJ	chronic
inflammatory	JJ	inflammatory
diseases	NNS	disease
,	,	,
such	JJ	such
as	IN	as
HAM	NNP	HAM
and	CC	and
uveitis	NN	uveitis
.	.	.
</s>
</p>
<p>
<s type="q">
The	DT	the
absence	NN	absence
of	IN	of
symptoms	NNS	symptom
in	IN	in
most	JJS	most
of	IN	of
the	DT	the
infected	VBN	infect
people	NNS	people
raises	VBZ	raise
the	DT	the
question	NN	question
of	IN	of
the	DT	the
multiple	JJ	multiple
etiological	JJ	etiological
roles	NNS	role
of	IN	of
the	DT	the
virus-associated	JJ	virus-associated
diseases	NNS	disease
and	CC	and
some	DT	some
of	IN	of
the	DT	the
interesting	JJ	interesting
questions	NNS	question
still	RB	still
unanswered	JJ	unanswered
includes	VBZ	include
:	:	:
does	VBZ	do
the	DT	the
immunogenic	JJ	immunogenic
characteristics	NNS	characteristic
of	IN	of
the	DT	the
host	NN	host
contribute	VB	contribute
to	TO	to
the	DT	the
upsurge	NN	upsurge
of	IN	of
symptoms	NNS	symptom
associated	VBN	associate
with	IN	with
HTLV-1	NNP	HTLV-1
infection	NN	infection
?	.	?
</s>
<s type="decl">
The	DT	the
present	JJ	present
manuscript	NN	manuscript
presents	VBZ	present
the	DT	the
most	RBS	most
relevant	JJ	relevant
published	VBN	publish
results	NNS	result
from	IN	from
several	JJ	several
laboratories	NNS	laboratory
,	,	,
including	VBG	include
ours	JJ	our
over	IN	over
the	DT	the
years	NNS	year
regarding	VBG	regard
the	DT	the
associations	NNS	association
between	IN	between
the	DT	the
genetic	JJ	genetic
variations	NNS	variation
of	IN	of
the	DT	the
host	NN	host
related	VBN	relate
to	TO	to
the	DT	the
immune	JJ	immune
response	NN	response
and	CC	and
HTLV-1	NNP	HTLV-1
infection	NN	infection
,	,	,
particularly	RB	particularly
those	DT	those
showing	VBG	show
the	DT	the
close	JJ	close
relationship	NN	relationship
between	IN	between
HTLV-1	NNP	HTLV-1
infection	NN	infection
and	CC	and
single	JJ	single
nucleotide	NN	nucleotide
polymorphisms	NNS	polymorphism
in	IN	in
genes	NNS	gene
of	IN	of
the	DT	the
immune	NN	immune
system	NN	system
.	.	.
</s>
</p>
</text>